Guest Blog

The Journal of Parkinson’s Disease invites scientists, clinicians, advocates and people with Parkinson’s to submit blog ideas for consideration. We strongly encourage those interested to reach out prior to drafting the post. Submissions should be sent to: journalofparkinsonsdisease@gmail.com

Any of the opinions expressed in guest blog posts on this website are the authors' own and do not nessarily reflect that of the journal, the Editors-in-Chief, or IOS Press.
. 

 

 

The International Linked Clinical Trials Initiative: A Program of Hope for Parkinson’s Disease

Cure Parkinson's (CP) started the international Linked Clinical Trials (iLCT) initiative to repurpose drugs for the treatment of Parkinson's disease (PD). Combining priorities with the Van Andel Institute (VAI), they hold an annual two-day meeting to present, examine, discuss, and prioritize suitable compounds for streamlining into clinical trials specifically for slowing down/stopping/reversing the progression of PD. I was an invited Parkinson’s patient advocate to the iLCT meeting held at the Van Andel Institute (Grand Rapids, MI, USA) last September 26-27, 2022. Herein is a synopsis of the iLCT program and meeting.

Last comment on by Katherine Bhana,

Mime Over Mind - a therapeutic tool to help manage Parkinson’s

I was living the dream. I’d retired as head of art from a busy downtown Toronto high school, my husband and I had moved to a smaller town, and our children were ‘launched’. We were traveling a lot, and I regularly visited my ‘happy place’ - painting. Except something was wrong with my dominant hand.

Last comment on by Katherine Bhana,

An Unbeatable Enemy

This blog post covers my approach to dealing with my symptoms. If I cannot run, I will walk; if I cannot walk, I will crawl; and if I cannot crawl, I will find someone to carry me. PD may be an unbeatable enemy (for now), but as long as I keep moving, it cannot win. Read my story here.

Last comment on by Bonnie Chismar,

Something to Cry About: Grief, Depression, and Parkinson’s Disease

This blog post was inspired by a Facebook post from a fellow Person with Parkinson’s Disease (PwP), that began: “I know that I am not as impaired as others here, but…” This was upsetting for me to read. I think that in the Parkinson’s community, we sometimes unconsciously shame people when they express their grief. Here, is what I want to say.

Last comment on by Leslie Bartnicki,

Getting About with Parkinson's

This blog post covers mobility issue for those with PD and means for overcoming these restrictions. Cycling, shown to be so valuable for PD sufferers, presents one key obstacle to overcome: getting on and off the bike. This can be resolved by exploiting recent technology developed for mountain bikes.

Last comment on by Bonnie Chismar,

Management of Constipation in Parkinson’s Disease by Bernoulli's Principle

What does a mathematical equation that deals with fluid pressure have to do with Parkinson’s disease? Dr Yoshiharu Uno explains.

Call to Action: Sharing of Patient-Level Data for Parkinson’s Research and Care

Sue Dubman has more than 20 years of experience in health care and research informatics for academia, industry and the government (NIH). Currently the Senior Director, Informatics Innovation, at University of California San Francisco Cancer Center, Sue is part of a multi-disciplinary team to innovate changes in clinical care and research. Diagnosed with Parkinson's disease (PD) in 2009, Sue has become an active advocate for improving the lives of those living with PD. Sue will have a poster at WPC 2016 (Exhibit Hall B, Level 1, Poster Board Number: P40.09).